P OLICY S ERIES No

Total Page:16

File Type:pdf, Size:1020Kb

P OLICY S ERIES No FRONTIER CENTRE FOR PUBLIC POLICY P OLICY S ERIES No. 236 / JULY 2021 IT ALL BEGAN IN CHINA BY BARRY COOPER AND MARCO NAVARRO-GÉNIE FRONTIER CENTRE FOR PUBLIC POLICY II deas that change your world / www.fcpp.org 1 FRONTIER CENTRE FOR PUBLIC POLICY BARRY COOPER Barry Cooper is a Senior Fellow with Frontier Centre for Public Policy. As a fourth generation Albertan, he was educated at Shawnigan Lake School, the University of British Columbia and Duke University, where he received his doctorate in 1969. He taught at Bishop’s University, McGill, and York University before coming to the University of Calgary in 1981. For the past twenty-five years he has studied western political philosophy, both classical and contemporary. Much of his teaching has focused on Greek political philosophy whereas his publications have been chiefly in the area of contemporary French and German political philosophy. Over the years he has spent considerable time in both countries, teaching and doing research. MARCO NAVARRO-GÉNIE Marco Navarro-Génie, BA (Concordia University), MA, PhD (University of Calgary), is a Senior Fellow who has served as vice-president of research at the Frontier Centre for Public Policy following two decades in academe. His areas of interests are fiscal federalism, higher education, immigration and labour, and energy and environment. He comments regularly on Canadian institutions, policy, and politics for various print and broadcast outlets. FRONTIER CENTRE FOR PUBLIC POLICY 203-2727 Portage Avenue, Winnipeg, Manitoba Canada R3J 0R2 Tel: 204-957-1567 Email: [email protected] The Frontier Centre for Public Policy is an independent, non-profit organization that undertakes research and education in support of economic growth and social outcomes that will enhance the quality of life in our communities. Through a variety of publications and public forums, Frontier explores policy innovations required to make the prairie region a winner in the open economy. It also provides new insights into solving important issues facing our cities, towns and provinces. These include improving the performance of public expenditures in important areas such as local government, education, health and social policy. The author(s) of this study have worked independently and the opinions expressed are therefore their own, and do not necessarily reflect the opinions of the board of the Frontier Centre for Public Policy. Copyright © 2021 by the Frontier Centre for Public Policy. Policy Series No. 236 • Date of First Issue: July 2021. Reproduced here with permission of the author(s). Any errors or omissions and the accuracy and completeness of this paper remain the responsibility of the author(s). Frontier Centre for Public Policy expresses its appreciation and thanks to the Lotte and John Hecht Memorial Foundation for supporting for this project. ISSN 1491-78 I deas that change your world / www.fcpp.org 2 FRONTIER CENTRE FOR PUBLIC POLICY P OLICY S ERIES No. 236 / JULY 2021 IT ALL BEGAN IN CHINA BY BARRY COOPER AND MARCO NAVARRO-GÉNIE TABLE OF CONTENTS The Beginning 4 SARS-CoV-2 Was Perfectable Adapted To Infect Humans 8 Politics As Much As Science Has Informed All Accounts of the Origin of the Virus 10 Other January 2020 Events 15 Taiwan’s Success Was Born of Distrust of Beijing’s Public Statements 16 The Joint WHO-China Study 18 Conclusion 21 Endnotes 23 3 FRONTIER CENTRE FOR PUBLIC POLICY THE BEGINNING Timelines associated with the spread of All warfare COVID-19 have changed over the past year and, with new information, may change again in the future. There seems to be is based on widespread agreement in publicly available sources that individuals with odd flu-like deception. illnesses were observed in China as early as August 2019. Nothing was publicly confirmed Sun Tsu, until a 70-year-old man with Alzheimer’s The Art of War, I: 18 disease was diagnosed in late December 2019 in Wuhan. According to the Lancet, which, despite recent irregularities, remains a flagship English-language general medical journal, the symptoms of this first patient presented around December 1.1 There also seems to be agreement that by late 2019 the “novel” coronavirus had jumped from an animal to a human being; this is called a zoonotic transmission. At this point, narrative agreement breaks down. Some observers said the transmission from an unspecified animal to a human took place in the Huanan Wholesale Seafood Market, also in Wuhan. It was called a “wet” market not simply because it sold slaughtered live seafood that requires water to live. It was also the site of the live slaughter of pangolins, wolf pups, hares, Sika deer, rabbits, bamboo rats, hedgehogs, snakes, raccoons, dogs, porcupines, badgers, pigs, salamanders (regular and giant), two types of crocodiles, geese, ducks, doves, chickens, and peacocks.2 A second narrative began with the infection of the wife of the patient with Alzheimer’s who showed symptoms of pneumonia at the end of the first week in December but who had no known history of exposure to the Wuhan wet market. She was then hospitalized in an isolation ward. Some observers then turned their attention to the Wuhan Institute of Virology, some 12 kilometers away from the market. 4 FRONTIER CENTRE FOR PUBLIC POLICY Others looked at the even closer (280 meters) they might mutate to become more infectious Wuhan Centre for Disease Control and to humans.”8 These experiments are called Prevention. The Wuhan virology lab, which “gain-of-function” or GoF experiments. As the happens to have close ties to the National name implies, they are intended to generate Microbiology Laboratory in Winnipeg,3 viruses with novel properties that may be was built by a contractor for the People’s more pathogenic and/or transmissible than Liberation Army (PLA) and is associated with wild viruses or even to generate viruses the Academy of Military Medical Sciences. with attributes that do not exist in nature.9 Evidently, the PLA sponsored research and Despite being routinely used, it would be an experiments in genetic editing, human understatement to say such experimentation performance enhancement, and similar is controversial.10 For that reason, the bioweapons work.4 It was intended to be a United States has banned GoF experiments top-level security laboratory (as well as a top- from time to time and they have not been secret one) that would be capable of safely conducted in the Winnipeg lab. They were handling the most deadly human pathogens. reinstated in the U.S. on December 19, 2017, The Chinese certified that it met Biosafety after having been discontinued there since Level Four (BSL-4), the highest safety rating October 2014.11 available, but many scientists outside China 12 viewed that classification skeptically. In Shi provided a different account. For 2017, an article in Nature raised questions context, two matters should be borne in about the safety protocols in Chinese mind. First, the Wuhan Institute of Virology microbiology labs, adding historical weight has been studying bats and bat diseases for to the possibility, raised early in the history a quarter-century. At the time, they were of the pandemic, that the virus may have concerned with discovering the origins of escaped from the Wuhan Institute of Virology SARS-1 or SARS-CoV-1. It turned out that the into the human population that frequented cross-species infection from bats to humans the market.5 was discovered relatively early. The Chinese scientists eventually traced the origin of the In January 2018, the United States sent SARS-1 virus to a cave in Yunnan province, scientists with diplomatic status to visit the over 1,200 kilometers south of Wuhan. The Wuhan virology lab. They discovered that nearest relative to SARS-CoV-2 is also a SARS-like coronaviruses from bats could coronavirus that the Wuhan lab isolated from interact with the human receptor found in the a horseshoe bat found in Yunnan in 2013.13 lungs, called ACE2, which “strongly suggests This virus, then called RaTG13, shared 96.4 that SARS-like coronaviruses from bats can percent of its genome with SARS-CoV-2. The be transmitted to humans to cause SARS-like 3.8 percent of genetic difference is equivalent diseases.”6 The Americans also found that the to between twenty and fifty years of natural lab personnel did not follow or practice BSL-4 evolutionary change. But, as we shall see, security protocols but were closer to BSL-2. that is not the whole story. In any event, how a bat in Yunnan led to an infection in Wuhan The Institute of Virology was controversial has yet to be definitively accounted for. for another reason. Virologist Shi Zhengli was nicknamed the “bat lady” for directing The second contextual factor is the adversarial a team that had accumulated an extensive geopolitical relationship between the United collection of coronaviruses from bat caves States and China. For example, Shi said that of southern China.7 She has also conducted then-president Donald Trump “owed us an experiments on bat viruses “to find out how apology” for suggesting that SARS-CoV-2 5 FRONTIER CENTRE FOR PUBLIC POLICY escaped from the Wuhan lab.14 denied doing so was entirely to be expected. What matters in this context is capability, not On July 15, 2020, Shi emailed Science with a a focus on accidents or intentions. reply to a series of written questions (a link is available in the Science article in the previous There remains yet another problem: about a footnote). When asked if a bat “in or close third of the original cluster of Wuhan cases to Wuhan” might have infected someone, had no exposure to the wet market, which she said that she favoured the theory that meant that COVID-19 was already spreading the virus spread through an intermediate through inter-human contact in December host.
Recommended publications
  • Microsoft Outlook
    Morris, Max From: Morris, Max Sent: Thursday, October 15, 2020 11:47 PM To: Morris, Max Subject: 10/15/2020 Coronavirus Daily Update These updates are being shared to multiple organizations, individuals and lists who/which are bcc’d. Best effort we are sending Daily updates during the business week, typically in the late afternoon or early evening, a Weekend Recap on Monday mornings, and any significant breaking news events provided anytime and on weekends. Please note some numbers included in the Statistics and news stories come from various sources and so can vary as they are constantly changing and not reported at the same time. All communications are TLP GREEN and can be shared freely. Know someone who might want to be added to our Updates? Of course ask them first, and then have them send us an email to [email protected]. Live the message, share the message: Be safe – Stay home and limit travel as much as possible, self-quarantine if you or any members of your family are or may be sick, if you go out wear your mask – the right way, ensure safe social distancing, and practice good hygiene – wash your hands, avoid touching your face, and sanitize used items and surfaces. Happy Thursday night Everyone! Well if I wait much longer we can say it’s Friday. Sorry for the late send but hope you All had a great day. The weekend is almost here. Following is the Daily Update with Highlights, the “Good Stuff”, Expanded Stories, statistics, trends and items of interest related to the novel coronavirus pandemic.
    [Show full text]
  • China Confronts Covid-19
    CHINA CONFRONTS COVID-19 By DAKE KANG and COLLEAGUES Associated Press STORY TK | ASSOCIATED PRESS 1 of 2 CRACKDOWN IN CHINA 1. CHINA DIDN’T WARN PUBLIC OF LIKELY PANDEMIC FOR 6 KEY DAYS April 15, 2020: Top Chinese ofcials secretly determined they were likely facing a pandemic from a new coronavirus in mid-January, ordering preparations even as they downplayed it in public. https://apnews.com/article/68a9e1b91de4fc166acd6012d82c2f9 2. CHINA DELAYED RELEASING CORONAVIRUS INFO, FRUSTRATING WHO June 3, 2020: Even as the World Health Organization publicly praised China, it privately complained about the lack of information it was getting on the new coronavirus. https://apnews.com/article/3c061794970661042b18d5aeaaed9fae 3. CHINA TESTING BLUNDERS STEMMED FROM SECRET DEALS WITH FIRMS Dec. 3, 2020: Secrecy and cronyism crippled China’s testing capacity in the early days of the outbreak, an Associated Press investigation has found. https://apnews.com/article/china-virus-testing-secret-deals-frms- 312f4a953e0264a3645219a08c62a0ad TABLE OF CONTENTS | ASSOCIATED PRESS https://apnews.com/article/68a9e1b91de4fc166acd6012d82c2f9 1 Xie Huanchi/Xinhua via AP Chinese President Xi Jinping talks by video with patients and medical workers at the Huoshenshan Hospital in Wuhan in central China’s Hubei Province in a video released March 10, 2020. April 15, 2020 China didn’t warn public of likely pandemic for 6 key days By ASSOCIATED PRESS Associated Press In the six days after top Chinese ofcials secretly determined they likely were facing a pandemic from a new coronavirus, the city of Wuhan at the epicenter of the disease hosted a mass banquet for tens of thousands of people; millions began traveling through for Lunar New Year celebrations.
    [Show full text]
  • WHO: Global Coronavirus Deaths Rise for 1St Time in 6 Weeks 22 March 2021
    WHO: Global coronavirus deaths rise for 1st time in 6 weeks 22 March 2021 the Philippines, Van Kerkhove said. The eastern Mediterranean region saw cases rise 8% percent, while the number of cases reported in the Americas and Africa declined. "I do want to mention that it had been about six weeks where we were seeing decreases in deaths," said Van Kerkhove. "And in the last week, we've started to see a slight increase in deaths across the world, and this is to be expected if we are to see increasing cases. But this is also a worrying sign." WHO emergencies chief Dr. Michael Ryan acknowledged an urge among the public in many Credit: Pixabay/CC0 Public Domain places to emerge from pandemic restrictions. Ryan insisted that any easing should coincide with measures such as strict case surveillance and high levels of vaccination, but said vaccines alone would A top World Health Organization expert on the not be enough. coronavirus pandemic said Monday the weekly global count of deaths from COVID-19 is rising "I'm afraid we're all trying to grasp at straws. We're again, a "worrying sign" after about six weeks of trying to find the golden solution: 'So we just get declines. enough vaccine and we push enough vaccine to people and that's going to take care of it,'" he said. Maria Van Kerkhove, technical lead on COVID-19 "I'm sorry, it's not." at the U.N. health agency, said the growth followed a fifth straight week of confirmed cases increasing © 2021 The Associated Press.
    [Show full text]
  • COVID-19: Make It the Last Pandemic
    COVID-19: Make it the Last Pandemic Disclaimer: The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Independent Panel for Pandemic Preparedness and Response concerning the legal status of any country, territory, city of area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Report Design: Michelle Hopgood, Toronto, Canada Icon Illustrator: Janet McLeod Wortel Maps: Taylor Blake COVID-19: Make it the Last Pandemic by The Independent Panel for Pandemic Preparedness & Response 2 of 86 Contents Preface 4 Abbreviations 6 1. Introduction 8 2. The devastating reality of the COVID-19 pandemic 10 3. The Panel’s call for immediate actions to stop the COVID-19 pandemic 12 4. What happened, what we’ve learned and what needs to change 15 4.1 Before the pandemic — the failure to take preparation seriously 15 4.2 A virus moving faster than the surveillance and alert system 21 4.2.1 The first reported cases 22 4.2.2 The declaration of a public health emergency of international concern 24 4.2.3 Two worlds at different speeds 26 4.3 Early responses lacked urgency and effectiveness 28 4.3.1 Successful countries were proactive, unsuccessful ones denied and delayed 31 4.3.2 The crisis in supplies 33 4.3.3 Lessons to be learnt from the early response 36 4.4 The failure to sustain the response in the face of the crisis 38 4.4.1 National health systems under enormous stress 38 4.4.2 Jobs at risk 38 4.4.3 Vaccine nationalism 41 5.
    [Show full text]
  • Here There Are Plans Taken to Bring It to Light”
    PANDA’S SCIENTIFIC ADVISORY BOARD SCOTT W. ATLAS SUCHARIT BHAKDI JAY BHATTACHARYA SUNETRA GUPTA SCOTT JENSEN MARTIN KULLDORFF MICHAEL LEVITT PAUL E. PETERSON ELLEN TOWNSEND MIKE YEADON OUR NETWORK “The truth ultimately prevails where there are plans taken to bring it to light” George Washington A WORLD GRIPPED BY FEAR THE FALSE NARRATIVE BEHIND THE A deadly novel virus is sweeping the planet. FEAR Nobody is immune and there is no cure. Asymptomatic people are major drivers of disease. So we have to lock down and wear masks until everyone is vaccinated. Anyone who challenges this narrative is a danger to society. UNJUSTIFIED FEAR IN THE FACE OF REALITY A virus that presents high risk to few and negligible risk to most hit some regions. THE REALITY Few are susceptible to severe disease. There are several available treatments. Asymptomatics are not major drivers of disease. Lockdowns and mask mandates, never recommended before, were tried. They haven’t worked and caused great harm. The vulnerable were hurt instead of helped. CFR= Deaths/ diagnosed A DEADLY cases VIRUS? IFR= Deaths/ total infected cases TEDROS ADHANOM “Reported case fatality rates, like the official 3.4% rate from the WHO, cause horror — and are NOT SO meaningless.” DEADLY 7 M A R C H 2 0 2 0 A review of 61 seroprevalence studies IFR: median is 0.23%, 0.05% for those below 70 1 4 O C T 2 0 2 0 JOHN IOANNIDIS NOT SO “The consequences of Covid-19 may DEADLY ultimately be more akin to those of a severe seasonal influenza” 2 6 M A R C H 2 0 2 0 ANTHONY FAUCI YOUNGER THAN 19 Y
    [Show full text]
  • COVID-19 Virtual Press Conference
    COVID-19 Virtual Press conference 2 October 2020 Speaker key: FC Fadela Chaib TAG Dr Tedros Adhanom Ghebreyesus MI Michelle MK Dr Maria Van Kerkhove MR Dr Michael Ryan BA Dr Bruce Aylward AN Anias KA Katrine GA Gabriela JA Jason KO Konstantin SS Dr Soumya Swaminathan LA Laurent AS Ashley EC Dr Emer Cook JO John MC Michael 00:00:49 FC Hello, everybody. I am Fadela Chaib, speaking to you from the Geneva WHO headquarters and welcoming you to our global COVID-19 press conference today, Friday, October 2nd. I'm sorry for the delay in starting this press conference. Today the briefing will focus on the COVID-19 epidemiological situation and overview. Before we go deep in developing this important aspect Dr Tedros, our Director-General, will address you first. Joining him in the room are Dr Mike Ryan, Executive Director, Emergencies Programme, Dr Maria Van Kerkhove, Technical Lead for COVID- 19, Dr Mariangela Simao, Assistant Director-General, Access to Medicines and Health Products, Dr Soumya Swaminathan, WHO Chief Scientist, and Dr Bruce Aylward, Senior Advisor to the Director-General and Lead on the ACT Accelerator. Welcome, all. This briefing is being translated simultaneously into the six official UN languages plus Portuguese and Hindi. Now without further ado I will hand over to Dr Tedros for his opening remarks. Dr Tedros, you have the floor. TAG Thank you, Fadela. Good morning, good afternoon and good evening. Overnight we heard that the President of the United States of America, Donald Trump, and First Lady, Melania Trump, tested positive for COVID-19.
    [Show full text]
  • MRC Centre for Outbreak Analysis and Modelling
    Centre for Outbreak Analysis and Modelling MRC Centre for ANNUAL REPORT Outbreak Analysis and Modelling www.imperial.ac.uk/medicine/outbreaks 2012 The Centre specialises in quantitative epidemiology encompassing mathematical modelling, statistical analysis and evolutionary epidemiology, to aid the control and Director’s message treatment of infectious diseases. April 2013 sees the Centre renewed for a second 5-year Consortium (led by Tim Hallett) and the Vaccine Modelling term, after we received an unprecedented 10 out of 10 Initiative – are up for renewal. However, grants are only score from the MRC subcommittee, which assessed the one aspect of the relationship. As important are the close performance of the Centre over its first term. Just as the working relationships between staff in the Centre and the work of the Centre over that time has been very much a Foundation, which sees our research increasingly used to team effort, so was the success of the renewal. inform Foundation strategy and delivery. The last few months have seen us start to drive through Despite its title, the Centre’s mission rapidly evolved to our strategy for the next 5 years. A crucial aspect of this encompass delivering innovative epidemiological analysis is to boost capacity in key research areas. It is therefore not only of novel infectious disease outbreaks, but also of my pleasure to welcome new academic staff into the endemic diseases of major global health significance. Our Centre. Xavier Didelot joined us last year as a lecturer in work on polio, malaria and HIV reflects this. However, the pathogen genetics, and our expertise in evolutionary and last few months have highlighted the ongoing relevance of genetic research will be further boosted this year by the our original mission to enhance preparedness and response recruitment of at least one additional member of academic to emerging disease threats.
    [Show full text]
  • Microsoft Outlook
    Morris, Max From: Morris, Max Sent: Wednesday, May 5, 2021 9:30 PM To: Morris, Max Subject: 05/05/2021 Coronavirus Daily Recap This email is provided for informational, non-commercial purposes only. Use or reliance on the information contained in this email is at your sole risk. This email is not provided by or affiliated in any way with Ally Financial Inc. These updates are being shared to multiple organizations, individuals and lists who/which are bcc’d. Best effort we are sending Daily updates during the business week, typically in the evening, a Weekend Recap on Monday mornings, and any significant breaking news events provided anytime. Please note some numbers included in the Statistics and news stories come from various sources and so can vary as they are constantly changing and not reported at the same time. All communications are TLP GREEN and can be shared freely. Know someone who might want to be added to our Updates? Of course ask them first, and then have them send us an email to [email protected]. Live the message, share the message: Be safe – Stay home and limit travel as much as possible, self-quarantine if you or any members of your family are or may be sick, if you go out wear your mask – the right way, ensure safe social distancing, and practice good hygiene – wash your hands, avoid touching your face, and sanitize used items and surfaces. And be sure to get fully vaccinated to not only protect yourself but others. Need to find a vaccine? Here are a few good sites and resources we have come across that may help: White House Vaccine Resource - Website to make it easier for people to find information, https://www.vaccines.gov/, and people can also text their zip code to 438829 to find out information about vaccination sites.
    [Show full text]
  • Weekly Digest of COVID-19 Guidelines
    Weekly Digest of COVID-19 Guidelines CDC ● (5/13) Updated G uidance for Fully Vaccinated People ○ Outside of the healthcare setting, fully vaccinated people no longer need to wear a mask or physically distance in any setting (except where required by federal, state, local, tribal, or territorial laws, rules, and regulations, including local business and workplace guidance) and can refrain from testing and quarantining following a known exposure unless they are residents or employees of a correctional or detention facility or a homeless shelter ● (5/12) S ARS-CoV-2 Variant Classifications and Definitions ○ A US government interagency group developed a Variant Classification scheme that defines three classes of SARS-CoV-2 variants: ■ Variant of Interest ■ Variant of Concern ■ Variant of High Consequence ○ The B.1.1.7, B.1.351, P.1, B.1.427, and B.1.429 variants circulating in the United States are classified as variants of concern. ● (5/7) S afety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March – April 2021 ○ By April 21, nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. Seventeen thrombotic events with thrombocytopenia have been reported, including three non-CVST events. ● (5/7) A nxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021 ○ Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine.
    [Show full text]
  • Enfoque Sociológico Sobre La Pandemia De Covid-19
    Enfoque sociológico sobre la pandemia de Covid-19. Enigmas y desafíos a la ciencia Raúl Rojas Soriano Junio de 2021 Diseño de la portada: Carlos Alberto Martínez Islas. Las imáge- nes fueron tomadas de Intenet D.R. © Raúl Rojas Soriano © Plaza y Valdés, S.A. de C.V. Plaza y Valdés, S.A. de C.V. Calle Alfonso Herrera 130, casa 11, colonia San Rafael, alcaldía Cuauhtémoc, CP. 06470. Ciudad de México. Correo electrónico: [email protected] www.plazayvaldes.com Queda permitido por los titulares del copyrigh, para uso personal y sin fines de lucro, la reproducción total o parcial, pero no la trans- formación a un formato distinto, de esta obra, citando como fuentes la dirección electrónica del autor <www.raulrojassoriano.com> y de la editorial <www.plazayvaldez.com>. isbn: 978-607-8624-85-0 www.raulrojassoriano.com www.facebook.com/rojassorianoraul @RojasSorianoR DEDICO este libro al personal Médico, de Enfermería, Trabajo Social y de otras áreas (Laboratorio e Inten- dencia) de México y de los demás países que lucha, o luchó (†), en la primera línea de batalla (los hos- pitales) contra la pandemia de Covid-19, en don- de muchos han contraído enfermedades orgánicas y mental-emocionales en cumplimiento de su noble deber. Mi más profundo reconocimiento por su invaluable dedicación para enfrentar en distintas trincheras, pero to- das importantes, esa enfermedad exponiendo su salud y la de sus familias, y laborando, además, en c.ondiciones de trabajo extremas que hacen más encomiable su esfuerzo. Dr. en Sociología Raúl Rojas Soriano ÍNDICE Palabras preliminares . 7 Capítulo I. Enfoque sociológico sobre la pandemia de Covid-19.
    [Show full text]
  • Towards Herd Immunity: Valuation of COVID-19 Vaccines
    ORTHOEVIDENCE+ www.myorthoevidence.com OEINSIGHTS+ Evidence, Analytics, Decisions Towards Herd Immunity: Valuation of COVID-19 Vaccines February 27, 2021 | Article No. 43 Contributors A yesha Siddiqua Msc PhD Mohit Bhandari MD FRCSC PhD Editor-in-Chief, OrthoEvidence Insights As of February 19, 2021, 11 COVID-19 vaccines have been approved by at least 1 country. Vaccines can help achieve herd immunity as they prevent a virus from spreading - when a virus keeps encountering individuals who have been already protected against infection, the chain of transmission is broken. Phase 3 trials have shown promising results for several vaccines (e.g., the Moderna: mRNA-1273 and Pfizer/BioNTech: BNT162b2 vaccines), while phase 3 results are still impending for few vaccines (e.g., the FBRI: EpiVacCorona and Bharat Biotech: Covaxin vaccines) that have already been approved by some countries. COVID-19 vaccines not only have unique production and deployment challenges, but many of them are simply unaffordable for low- and middle-income countries. Many high income countries have pre-purchased large proportions of vaccines, which raises serious allocation concerns for the rest of the world. Herd immunity will not be achieved by only vaccinating selected populations given the transient nature of the spread of SARS-CoV-2 that knows no borders - a COVID-19 outbreak anywhere is an outbreak everywhere in the world. Investment in equitable and sustainable vaccine strategies at the global scale will be the only way to win the battle against this pandemic. OEINSIGHTS www.myorthoevidence.com 1 Powered by OE Mind Insights “Billions of individuals around the world might not have access to COVID-19 vaccines in 2021, which could prolong the pandemic and raise the risk of further mutations of the virus emerging, possibly undermining the efficacy of existing vaccines.” Wouters et al (2021) (1) After a year of the COVID-19 pandemic being characterized by chaos and uncertainty, there is finally some hope on the horizon with the emergence of some successful vaccines.
    [Show full text]
  • Improving Pandemic Preparedness: Lessons from COVID-19
    Independent Task Force Report No. 78 Improving Pandemic Preparedness Lessons From COVID-19 Sylvia Mathews Burwell and Frances Fragos Townsend, Chairs Thomas J. Bollyky and Stewart M. Patrick, Project Directors Independent Task Force Report No. 78 Improving Pandemic Preparedness Lessons From COVID-19 Sylvia Mathews Burwell and Frances Fragos Townsend, Chairs Thomas J. Bollyky and Stewart M. Patrick, Project Directors The Council on Foreign Relations (CFR) is an independent, nonpartisan membership organization, think tank, and publisher dedicated to being a resource for its members, government officials, business executives, journalists, educators and students, civic and religious leaders, and other interested citizens in order to help them better understand the world and the foreign policy choices facing the United States and other countries. Founded in 1921, CFR carries out its mission by maintaining a diverse membership, with special programs to promote interest and develop expertise in the next generation of foreign policy leaders; convening meetings at its headquarters in New York and in Washington, DC, and other cities where senior government officials, members of Congress, global leaders, and prominent thinkers come together with Council members to discuss and debate major international issues; supporting a Studies Program that fosters independent research, enabling CFR scholars to produce articles, reports, and books and hold roundtables that analyze foreign policy issues and make concrete policy recommendations; publishing Foreign Affairs, the preeminent journal on international affairs and U.S. foreign policy; sponsoring Independent Task Forces that produce reports with both findings and policy prescriptions on the most important foreign policy topics; and providing up-to- date information and analysis about world events and American foreign policy on its website, CFR.org.
    [Show full text]